This tyrosine analog includes tert-butyl ether protection and α-methyl substitution that restricts backbone mobility. Researchers employ it to manipulate aromatic environment, steric constraints, and conformational bias. Its dual protections provide precise synthetic control. The residue is valuable in stabilized peptide frameworks.
CAT No: R2117
CAS No:1309873-74-2
Synonyms/Alias:1309873-74-2;Fmoc-|A-Me-Tyr(tBu)-OH;N-Fmoc-a-methyl-4-tert-butoxy-L-phenylalanine;O-(1,1-Dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-alpha-methyl-L-tyrosine;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butoxy)phenyl)-2-methylpropanoic acid;(S)-2-Fmoc-amino-3-(4-(tert-butoxy)phenyl)-2-methylpropanoic acid;(2S)-3-[4-(tert-butoxy)phenyl]-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-2-methylpropanoic acid;MFCD32696669;Fmoc-(Me)Tyr(tBu)-OH;SCHEMBL25362437;AKOS005067684;AT30251;CS-0439220;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methyl-3-[4-[(2-methylpropan-2-yl)oxy]phenyl]propanoic acid;
3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.